(Press-News.org) CLEVELAND, Ohio (October 3, 2013) -- The mix of bacteria in the vagina changes as women go through menopause. And a certain mix is typical after menopause in women who have vulvovaginal atrophy (VVA), a common cause of vaginal dryness and sexual pain, finds a team at Johns Hopkins and the University of Maryland. They suspect these bacteria may play a role in causing VVA and that personalized probiotics or other ways to manage the bacterial mix might prevent or treat VVA in the future. Their study was published online today in Menopause, the journal of The North American Menopause Society.
Lubricants with intercourse or vaginal moisturizers are considered first-line therapies for women with VVA symptoms. And when VVA is moderate to severe, low-dose estrogen in the vagina is the therapeutic standard. But these therapies have drawbacks. Some women, including certain cancer survivors, cannot use vaginal estrogen, and some women don't wish to use hormones. On the other hand, some lubricants or moisturizers may have detrimental effects on the bacterial mix or the vaginal lining or may even increase a woman's susceptibility to infction. So, alternative treatments such as probiotics will certainly be welcome.
Knowing just what bacterial mixes are healthy or unhealthy is the critical first step toward modifying the mix to treat the troubles. In their study of 87 women from 35 to 60 years old, the investigators found that distinct mixes were typical of the different stages of a woman's reproductive life and that a certain mix that becomes much more common after menopause was typical in the women who had VVA symptoms.
All these distinct mixes have types of Lactobacillus in them, a genus of bacteria typical in yogurt cultures and over-the-counter probiotics. When levels of Lactobacillus bacteria are low, the vagina tends to be dry. But the article's authors think that using products like these with lactobacilli that aren't native to an individual woman's vagina might do more harm than good. Personalized probiotics may be needed to treat or prevent VVA.
###
The article, "Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy," will be published in the May print edition of Menopause.
Founded in 1989, The North American Menopause Society (NAMS) is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field—including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education—makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit http://www.menopause.org.
New study suggests changing bacterial mix may lead to painful sex after menopause
2013-10-03
ELSE PRESS RELEASES FROM THIS DATE:
Health of honey bees adversely impacted by selenium
2013-10-03
RIVERSIDE, Calif. — Traditionally, honey bee research has focused on environmental stressors such as pesticides, pathogens and diseases. Now a research team led by entomologists at the University of California, Riverside has published a study that focuses on an anthropogenic pollutant: selenium (Se).
The researchers found that the four main forms of Se in plants — selenate, selenite, methylselenocysteine and selenocystine — cause mortality and delays in development in the honey bee.
"Metal pollutants like selenium contaminate soil, water, can be accumulated in plants, ...
Researchers unveil method for creating 're-specified' stem cells for disease modeling
2013-10-03
Boston, Mass., Oct. 3, 2013 – In a paper in Cell Stem Cell, a team led by researchers in the Boston Children's Hospital's Stem Cell Transplantation Program reports a new approach for turning induced pluripotent stem cells (iPSCs) into hematopoietic stem and progenitor cells for in vivo disease modeling.
With this strategy—which they call re-specification—the team, including Sergei Doulatov, PhD, and George Daley, MD, PhD, of Boston Children's, may have overcome technical barriers to generating blood disease-specific animal models from the thousands of iPSC cell lines ...
Old remedy shows promise as new chemo drug for bladder cancer
2013-10-03
MAYWOOD, Il. – An old home remedy called ipecac syrup, once stocked in medicine cabinets in case of accidental poisoning, is showing promise as a new chemotherapy drug for bladder cancer.
Years ago, ipecac syrup was used to induce vomiting in poisoning cases. Now a Loyola University Medical Center study has found that the active ingredient of ipecac syrup effectively inhibits the growth of bladder cancer cells, especially when combined with a standard chemotherapy drug.
The study by corresponding authors Kimberly Foreman, PhD, Gopal Gupta, MD, and colleagues is published ...
No kissing or singing in the rain
2013-10-03
Since remote times humans have been interested in the weather and have used different strategies to predict bad storms. Some of these strategies rely on the observation that in anticipation of storms, birds fly at low heights and cows lie down. Some people even claim to feel their bones ache. These and other similar accounts have been reported but not scientifically tested.
In a paper entitled Weather Forecasting by Insects: Modified Sexual Behaviour in Response to Atmospheric Pressure Changes, the group of Dr José Maurício Simões Bento at University of São Paulo (College ...
Insects modify mating behavior in anticipation of storms
2013-10-03
Insects modify calling and courting mating behavior in response to changes in air pressure, according to results published October 2 in the open-access journal PLOS ONE by Ana Cristina Pellegrino and José Maurício Bento, University of São Paulo, and colleagues from other institutions. The bugs' ability to predict adverse weather conditions may help them modify their mating behavior during high winds and rain, reducing risk of injury or even death.
Researchers studied mating behavior changes in the curcurbit beetle, the true armyworm moth, and the potato aphid under falling, ...
Depression may increase your risk of Parkinson's disease
2013-10-03
MINNEAPOLIS -- People who are depressed may have triple the risk of developing Parkinson's disease, according to a study published in the October 2, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
"Depression is linked in other studies to illnesses such as cancer and stroke," said study author Albert C. Yang, MD, PhD, with Taipei Veterans General Hospital in Taipei, Taiwan. "Our study suggests that depression may also be an independent risk factor for Parkinson's disease."
Researchers analyzed the medical records of 4,634 ...
Scientists find insect DEET receptors, develop safe alternatives to DEET
2013-10-03
RIVERSIDE, Calif. — Insects are repelled by N,N-diethyl-m-toluamide, also known as DEET. But exactly which olfactory receptors insects use to sense DEET has eluded scientists for long.
Now researchers at the University of California, Riverside have identified these DEET-detecting olfactory receptors that cause the repellency — a major breakthrough in the field of olfaction.
Further, the team of researchers has identified three safe compounds that mimic DEET and could one day be used to prevent the transmission of deadly vector-borne diseases such as malaria, dengue, ...
International study shows efficacy of new gastric cancer drug
2013-10-03
Barcelona, 03 October 2013. This international trial, published in The Lancet, is one of the largest phase III trials in second-line treatment of gastric cancer. Standard care for advanced gastric cancer, known as first-line treatment, is based on chemotherapy, but it only offers a median survival of 8 to 10 months.
The trial investigated the use of ramucirumab, an antibody developed to treat solid tumours that targets Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2), a key receptor in the angiogenesis process. It showed that ramucirumab effectively inhibits a ...
Newly identified biomarkers help predict outcome in deadly lung disease
2013-10-03
New Haven, Conn. – A Yale-led study has identified a gene expression profile that can predict outcomes and lead to better treatment for one of the most lethal lung diseases, idiopathic pulmonary fibrosis (IPF). The study appears in Science Translational Medicine.
IPF causes progressive scarring of the lungs, leading to cough, shortness of breath, and potentially death. In most cases, the cause cannot be identified, and there is no cure other than a lung transplant. While some patients experience a progressive course that leads to death within one to two years, others ...
Long-term cognitive impairment too common after critical illness
2013-10-03
Patients treated in intensive care units across the globe are entering their medical care with no evidence of cognitive impairment but oftentimes leaving with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer's disease (AD) that persists for at least a year, according to a Vanderbilt study published today in the New England Journal of Medicine.
The study, led by members of Vanderbilt's ICU Delirium and Cognitive Impairment Group, found that 74 percent of the 821 patients studied, all adults with respiratory failure, cardiogenic ...